Kr. Flaherty et al., Short-term and long-term outcomes after bilateral lung volume reduction surgery - Prediction by quantitative CT, CHEST, 119(5), 2001, pp. 1337-1346
Citations number
43
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objectives: To evaluate selection criteria and duration of benefit for pati
ents undergoing lung volume reduction surgery (LVRS).
Methods: Eighty-nine consecutive patients with severe emphysema who underwe
nt bilateral LVRS were prospectively followed up for up to 3 years. Patient
s underwent preoperative pulmonary function testing, 6-min walk, chest CT,
and answered a baseline dyspnea questionnaire. CT scans in 65 patients were
analyzed for emphysema extent and distribution using the percentage of emp
hysema in the lung, percentage of normal lower lung, and the CT emphysema r
atio (CTR, an index of the craniocaudal distribution of emphysema). All pat
ients underwent at least 6 weeks of pulmonary rehabilitation prior to surge
ry Outcome measures were FEV1, 6-min walk distance, and transitional dyspne
a index (TDI),
Results: Compared to baseline, FEV, was significantly increased at 3, 6, 12
, 18, 24, and 36 months after surgery (p less than or equal to 0.008). The
6-min walk distance increased from 871 feet (baseline) to 1,110 feet (3 mon
ths), 1,214 feet (6 months), 1,326 feet (12 months), 1,342 feet (18 months)
, 1,371 feet (24 months), and 1,390 feet (36 months) after surgery. Despite
a decline in FEV, over time, B-min walk distance was preserved. Dyspnea as
measured by TDI improved at 3, 6, 12, 18, 24, and 36 months after surgery.
A high CTR was the best predictor of a 12% increase over baseline and an a
bsolute increase of 200 mt in FEV,, although with a lo,v area under the rec
eiver operating characteristic curve. In addition, the sensitivity and nega
tive predictive value of the CTR were limited. No radiographic or physiolog
ic predictor was able to consistently predict a successful increase in walk
distance or TDI,
Conclusion: LVRS improves pulmonary function, decreases dyspnea, and enhanc
es exercise capacity in many patients with severe emphysema, although impro
vement wanes 36 months after surgery.